← Leaderboards
Daniel Whibley
University Of Michigan At Ann Arbor
$2,261,590
Attributed
$2,261,590
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $779.5K · FY2023–25$1M$750K$500K$250K$0
'23
'24
'25
Funding mix
By agency
NIH$2,261,590 · 1
By mechanism
R01$2,261,590 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Michigan At Ann Arbor
Same institution · by research overlap
- Alexandre Dasilva$11,229,322
- Chad M Brummett$8,965,950
- Richard E Harris$13,043,112
- Steven Edward Harte$6,619,782
- David A Williams$9,300,445
Others in their field
Other Rising Stars on “Acceptability And Feasibility”
- Schenita D. Randolph · Duke University$3,870,187
- Saeed Ahmed · Baylor College Of Medicine$3,372,206
- Tanya L Zakrison · University Of Chicago$3,254,872
- Czarina Navos Behrends · Weill Medical Coll Of Cornell Univ$3,156,884
- Keith Copelin Ferdinand · Tulane University Of Louisiana$2,797,027
- Heather Zierhut · University Of Minnesota$2,600,212
Research focus
Acceptability And FeasibilityAdherenceAdoptionAdultAffectAlgorithmsAnxiety SymptomsAwarenessBehavioralBehavior ChangeBehavior TherapyBiopsychosocialCentral PainCharacteristicsChronic PainClinical Practice GuidelineClinical TrialsCognitiveCognitive TherapyCompare EffectivenessDegenerative PolyarthritisDepressive SymptomsDigitalAccelerometer
Grant awards (3)
Move and Snooze: Adding insomnia treatment to an exercise program to improve pain outcomes in older adults with knee osteoarthritis$727,607
R01 · FY2025 · AG · contact PI
Move and Snooze: Adding insomnia treatment to an exercise program to improve pain outcomes in older adults with knee osteoarthritis$754,467
R01 · FY2024 · AG · contact PI
Move and Snooze: Adding insomnia treatment to an exercise program to improve pain outcomes in older adults with knee osteoarthritis$779,516
R01 · FY2023 · AG · contact PI